Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-15
2011-12-27
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S309700
Reexamination Certificate
active
08084484
ABSTRACT:
Vanilloid receptor ligand compounds corresponding to formula I:pharmaceutical compositions containing such compounds, a process for producing such compounds, and methods of using such compounds for treating or inhibiting pain and various other disorders or conditions.
REFERENCES:
patent: 2005/0113576 (2005-05-01), Lee et al.
patent: WO 03/070247 (2003-08-01), None
patent: WO 2005/016890 (2005-02-01), None
Chalmers (TiPS vol. 17, pp. 166-172 Apr. 1996).
International Search Report mailed Oct. 30, 2008 with English translation, sixteen (16) pages.
International Preliminary Report on Patentability mailed Nov. 19, 2009, with English translation, thirteen (13) pages.
S. Marinelli et al., The Journal of Neuroscience, vol. 23, Issue 8, pp. 3136-3144 (2003).
Donnerer J. , Liebmann I., Schicho R., Pharmacology. Feb. 2005; vol. 73, Issue 2, pp. 97-101 (2005) E pub Oct. 18, 2004.
V. Micale et al., Neurobiology of Disease, Issue 36, pp. 70-80 (2009).
M. Fu et al., Medical Hypotheses vol. 73, pp. 100-102 (2009).
C. Maggi, Life Sciences, vol. 51, No. 23, pp. 1777-1781 (1992).
H. Rami et al., Therapeutic Strategies, vol. 1, Issue 1, pp. 97-104 (2004).
L.A. Birder et al., Nature Neuroscience, vol. 5, No. 9, pp. 856-860 (2002).
P. Holzer, European Journal of Pharmacology vol. 500, pp. 231-241 (2004).
Y. Yiangou et al., The Lancet, vol. 357, p. 1338-1339, Apr. 28, 2001.
P. Geppetti et al., British Journal of Pharmacology, vol. 141, No. 8, pp. 1313-1320 (2004).
W. Huang et al., Journal of Hypertension vol. 27 (2009).
E. Bodo et al., American Journal of Pathology, vol, 166, No. 4, pp. 985-998 (2005).
Won-Sik Shim et al., The Journal of Neuroscience, vol. 27, No. 9, pp. 2331-2337 (2007).
F. Leung, Life Sciences, Issue 83, pp. 1-5 (2008).
A. Suri et al., TRENDS in Pharmacological Sciences, vol. 29, No. 1, pp. 29-36 (2007).
G. Ahern, The Journal of Biological Chemistry, vol. 278, No. 33, pp. 30429-30434 (2003).
I.-J. You et al., Soc. Neurosci. Abstr. vol. 912.22 (2007).
J. Li et al., Pharmacological Research vol. 57, Issue 3, pp. 239-246 (2008).
H. Schultz, Journal of Physiology, 551.2, p. 400 (2003).
M. Zahner et al., Journal of Physiology 551.2, pp. 515-523 (2003).
H. Pan et al., Circulation Journal of the American Heart Association, Circulation vol. 110, Issue 13, pp. 1826-1831 (2004).
M. Ghasemi et al., European Journal of Pharmacology vol. 544, Issues 1-3, pp. 138-145 (2006).
S. Mandadi et al., Neuroscience vol. 162 pp. 1377-1397 (2009).
D. Dawbarn et al., Neuropharmacology, vol. 20, pp. 341-346 (1981).
R. Marsch et al., The Journal of Neuroscience, vol. 27, No. 4, pp. 832-839 (2007).
H. Eilers, Molecular Interventions, vol. 8, Issue 5, pp. 226-229 (2008).
Bahrenberg Gregor
Christoph Thomas
De Vry Jean
Frank Robert
Lee Jeewoo
Crowell & Moring LLP
Gruenenthal GmbH
Habte Kahsay T
LandOfFree
Vanilloid receptor ligands, pharmaceutical compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vanilloid receptor ligands, pharmaceutical compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vanilloid receptor ligands, pharmaceutical compositions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4308289